+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Autoimmune Drug"

From
Autoimmune Drugs - Global Strategic Business Report - Product Thumbnail Image

Autoimmune Drugs - Global Strategic Business Report

  • Report
  • March 2026
  • 287 Pages
  • Global
From
From
Autoimmune Treatment Market Report 2026 - Product Thumbnail Image

Autoimmune Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Autoimmune Collaboration and Licensing Deals 2016-2025 - Product Thumbnail Image

Autoimmune Collaboration and Licensing Deals 2016-2025

  • Report
  • October 2025
  • 500 Pages +
  • Global
From
Autoimmune Disease Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Autoimmune Disease Drugs Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 193 Pages
  • Global
From
Upadacitinib Market - Global Forecast 2025-2032 - Product Thumbnail Image

Upadacitinib Market - Global Forecast 2025-2032

  • Report
  • November 2025
  • 186 Pages
  • Global
From
From
Rituximab - Global Strategic Business Report - Product Thumbnail Image

Rituximab - Global Strategic Business Report

  • Report
  • March 2026
  • 378 Pages
  • Global
From
C-X-C Chemokine Receptor Type 2 Market Report 2026 - Product Thumbnail Image

C-X-C Chemokine Receptor Type 2 Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Hashimotos Disease Market Report 2026 - Product Thumbnail Image

Hashimotos Disease Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Tenosynovitis Drugs Market Report 2026 - Product Thumbnail Image

Tenosynovitis Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
From
From
Upadacitinib Market Report 2026 - Product Thumbnail Image

Upadacitinib Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Autoimmune Monoclonal Antibody Market Report 2026 - Product Thumbnail Image

Autoimmune Monoclonal Antibody Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Ankylosing Spondylitis - Pipeline Insight, 2025 - Product Thumbnail Image

Ankylosing Spondylitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Moderate To Severe Plaque Psoriasis- Pipeline Insight, 2025 - Product Thumbnail Image

Moderate To Severe Plaque Psoriasis- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Loading Indicator

The Autoimmune Drug market is a subset of Immune Disorders Drugs, which are used to treat a variety of conditions caused by an overactive immune system. These drugs are designed to reduce inflammation, suppress the immune system, and prevent the body from attacking its own tissues. Common autoimmune diseases that are treated with these drugs include rheumatoid arthritis, psoriasis, lupus, and multiple sclerosis. Autoimmune drugs are typically administered orally, intravenously, or topically, depending on the condition being treated. They can be used alone or in combination with other treatments, such as physical therapy or lifestyle changes. Notable companies in the Autoimmune Drug market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more